Latest Dendreon Stories
HONG KONG, March 1 /PRNewswire/ - Today, www.WorldStreetFundamentals.com released its industry report highlighting Dendreon Corp. (NASDAQ: DNDN) and Human Genome Sciences, Inc. (NASDAQ: HGSI).
SEATTLE, Feb. 24, 2011 /PRNewswire/ -- Dendreon Corporation (Nasdaq: DNDN) today announced that management will present at the following conferences: Citi Global Health Care Conference, New York, NY on March 2, 2011 at 2:30 p.m.
SEATTLE, Feb. 17, 2011 /PRNewswire/ -- Dendreon Corporation (Nasdaq: DNDN) today announced the following data presentations taking place at the 2011 Genitourinary Cancers Symposium annual meeting in Orlando, Florida.
MIAMI BEACH, Fla., Feb.
SEATTLE, Feb. 8, 2011 /PRNewswire/ -- Dendreon Corporation (Nasdaq: DNDN) today announced that management will host a conference call on Tuesday, March 1, 2011 at 4:30 p.m. ET to review fourth quarter and year-end financial results.
WORCESTER, Mass., Feb. 3, 2011 /PRNewswire/ -- Generex Biotechnology Corporation (www.generex.com) (OTC Bulletin Board: GNBT), together with its wholly-owned immunotherapeutic vaccines subsidiary, Antigen Express, Inc.
VANCOUVER, Canada, Jan. 21, 2011 /PRNewswire-Asia/ -- Insiderslab.com issues new research reports that highlight large insider trades found in for Oracle, Hewlett-Packard, State Street, Walt Disney, Aruba, & Dendreon.
- Growing in low tufty patches.